Table 1.
Functional and clinical parameters, according to gender
| Total (N = 594) | Men (N = 231) | Women (N = 363) | P-value | |
|---|---|---|---|---|
| Age (years) | 78.71 7.12 | 78.18 7.04 | 79.04 7.14 | 0.137 |
| MPI | 0.46 0.24 | 0.43 0.24 | 0.48 0.24 | 0.008 |
| ADL | 3.57 2.49 | 3.73 2.52 | 3.47 2.47 | 0.105 |
| IADL | 3.31 3.13 | 3.27 3.06 | 3.34 3.18 | 0.952 |
| SPMSQ | 3.37 3.31 | 2.94 3.37 | 3.65 3.24 | < 0.001 |
| MNA | 20.57 5.76 | 21.36 5.86 | 20.08 5.66 | < 0.001 |
| CIRS | 3.25 1.82 | 3.29 1.82 | 3.22 1.83 | 0.553 |
| DRUGS | 4.60 2.87 | 4.70 3.06 | 4.53 2.75 | 0.481 |
| ESS | 15.08 3.81 | 15.55 3.84 | 14.77 3.77 | 0.008 |
| N (%) | N (%) | N (%) | ||
| Hypertension | 227 (38.22) | 75 (32.47) | 152 (41.87) | 0.022 |
| Cerebrovascular diseases | 197 (33.16) | 78 (33.77) | 119 (32.78) | 0.804 |
| Neurodegenerative diseases | 173 (29.12) | 66 (28.57) | 107 (29.48) | 0.213 |
| Heart diseases | 164 (27.61) | 75 (32.47) | 89 (24.52) | 0.038 |
| Respiratory failure | 41 (6.90) | 16 (6.93) | 25 (6.89) | 0.985 |
| Kidney diseases | 20 (3.37) | 8 (3.46) | 12 (3.31) | 0.917 |
| Liver cirrhosis | 11 (1.85) | 5 (2.16) | 6 (1.65) | 0.652 |
| Miscellaneous | 121 (20.37) | 44 (19.05) | 77 (21.21) | 0.601 |
| 1-month mortality (ev per pm, IR%) | 40/569 (7.0%) | 14/223 (6.3%) | 26/346 (7.5%) | 0.438 |
| 1-year mortality (ev per py, IR%) | 109/518 (21.0%) | 46/202 (22.8%) | 63/316 (20.0%) | 0.547 |
pm, person/months; py, person/years; IR%, incidence rate%.
MannWhitney U-test and chi-square test were assessed for continuous and categorical variables, respectively.